DDI Publications List

Tuomilehto J, Schwarz PE. Preventing Diabetes: Early Versus Late Preventive Interventions. Diabetes Care. 2016;39 Suppl 2:S115-20.

AlSeaidan M, Al Wotayan R, Christophi CA, Al-Makhseed M, Abu Awad Y, Abraham S, et al. Birth Outcomes in a Prospective Pregnancy-Birth Cohort Study of Environmental Risk Factors in Kuwait: The TRACER Study. Paediatr Perinat Epidemiol. 2016;30(4):408-17.

Walford GA, Gustafsson S, Rybin D, Stancakova A, Chen H, Liu CT, Hong J, Jensen RA, Rice K, Morris AP… Tuomilehto J, et al. Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci. Diabetes. 2016;65(10):3200-11.

NCD Risk Factor Collaboration (NCD-RisC), Tuomilehto J. et al. A century of trends in adult human height. eLife. 2016;5.

Matz K, Seyfang L, Dachenhausen A, Teuschl Y, Tuomilehto J, Brainin M, MD for the Austrian Stroke Unit Registry Collaborators. Post-stroke pneumonia at the stroke unit - a registry based analysis of contributing and protective factors. BMC Neurol. 2016;16:107.

Cefalu WT, Buse JB, Tuomilehto J, Fleming GA, Ferrannini E, Gerstein HC, Bennett PH, Ramachandran A, Raz I, Rosenstock J, Kahn SE. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care. 2016;39(7):1186-201.

Hassoun AA, Pathan MF, Medlej RC, Alarouj M, Shaltout I, Chawla MS, et al. Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study. Diabetes Metab Syndr Obes. 2016;9:225-31.

Akhtar S, Alroughani R, Ahmed SF, Al-Hashel JY. Prognostic indicators of secondary progression in a paediatric-onset multiple sclerosis cohort in Kuwait. Mult Scler. 2016;22(8):1086-93.

Welsh P, Cezard G, Gill JM, Wallia S, Douglas A, Sheikh A, Wild SH, Tuomilehto J, McKnight J, Murray G… et al. Associations between weight change and biomarkers of cardiometabolic risk in South Asians: secondary analyses of the PODOSA trial. Int J Obes (Lond). 2016;40(6):1005-11.

Vinik AI, Smith AG, Singleton JR, Callaghan B, Freedman BI, Tuomilehto J, Bordier L, Bauduceau B, Roche F. Normative Values for Electrochemical Skin Conductances and Impact of Ethnicity on Quantitative Assessment of Sudomotor Function. Diabetes Technol Ther. 2016;18(6):391-8.

Scott LJ, Erdos MR, Huyghe JR, Welch RP, Beck AT, Wolford BN, Chines PS, Didion JP, Narisu N, Stringham HM… Tuomilehto J, et al. The genetic regulatory signature of type 2 diabetes in human skeletal muscle. Nat Commun. 2016;7:11764.

Lindstrom J, Uusitupa M, Tuomilehto J, Peltonen M. Following in the Footsteps of the North Karelia Project: Prevention of Type 2 Diabetes. Glob Heart. 2016;11(2):223-8.

Leng J, Liu G, Zhang C, Xin S, Chen F, Li B, Tian H, Yu Z, Tuomilehto J, Hu G, Yang X. Physical activity, sedentary behaviors and risk of gestational diabetes mellitus: a population-based cross-sectional study in Tianjin, China. Eur J Endocrinol. 2016;174(6):763-73.

Laatikainen T, Nissinen A, Kastarinen M, Jula A, Tuomilehto J. Blood Pressure, Sodium Intake, and Hypertension Control: Lessons From the North Karelia Project. Glob Heart. 2016;11(2):191-9.

Jolle A, Midthjell K, Holmen J, Tuomilehto J, Carlsen SM, Shaw J, Asvold BO. Impact of sex and age on the performance of FINDRISC: the HUNT Study in Norway. BMJ Open Diabetes Res Care, 2016;4(1):e000217.

Shaltout AA, Channanath AM, Thanaraj TA, Omar D, Abdulrasoul M, Zanaty N, et al. Ketoacidosis at first presentation of type 1 diabetes mellitus among children: a study from Kuwait. Sci Rep. 2016;6:27519.

AlSaggaf W, Asiri M, Ajlan B, Afif AB, Khalil R, Salman AB, Alghamdi A, Bashawieh O, Alamoudi A, Aljahdali A, …Tuomilehto J, et al. Reported Benefits of Insulin Therapy for Better Glycemic Control in Type 2 Diabetic Patients-Is This Applicable in Saudi Patients? Clin Med Insights Endocrinol Diabetes.2016;9:13-7.

Baothman OA, Zamzami MA, Taher I, Abubaker J, Abu-Farha M. The role of Gut Microbiota in the development of obesity and Diabetes. Lipids Health Dis. 2016;15:108.

Laatikainen L, Ojamo M, Rudanko SL, Summanen P, Keinanen-Kiukaanniemi S, Tuomilehto J, Herrala S, Uusitalo H. Improving visual prognosis of the diabetic patients during the past 30 years based on the data of the Finnish Register of Visual Impairment. Acta Ophthalmol. 2016;94(3):226-31.

Barengo NC, Tuomilehto J. How can we identify candidates at highest risk--to screen or not to screen? Herz. 2016;41(3):175-83.